en · de · es · pt
aod-9604-notes.peptides9002.com › Wiki › Identity And Molecular Context — Background and Details

Identity And Molecular Context — Background and Details

By Editorial Desk · published 2025-09-27 · last reviewed 2025-11-06 · Wiki

The short version of metabolic research fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2025-11-06 and is reviewed periodically as new material appears.

Identity and Molecular Context

The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.

Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.

Background And Research Context

In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.

AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.

The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.

Aod-9604 at a glance

PropertyValueNotes
Molecular classSynthetic peptideDerived from a fragment of human growth hormone
Sequence basishGH residues 176-191Commonly described as a 16-amino-acid fragment
AppearanceWhite to off-white powderTypical for lyophilized research peptides
SolubilitySoluble in water or aqueous bufferExact solubility depends on pH and purity
Common synonymsAOD9604; hGH 176-191Spelling and punctuation vary across sources

Background and Development History

Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.

AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.

Related pages on this site

Identity and Research Origin

Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.

AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.

Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.

Background from the literature

Todd appeared in more than 100 theatrical and television films and played opposite many major Hollywood stars. His film credits include: Platoon (1986), Night of the Living Dead (1990), Candyman (1992), The Crow (1994), The Rock (1996), Wishmaster (1997), the Final Destination series (2000–2025), Minotaur (2006), and Beg (2010). Todd was the voice of The Fallen in Transformers: Revenge of the Fallen (2009) and was also in the Rel Dowdell film Changing the Game. Todd was a special guest of the Weekend of Horror Creation Entertainment on May 23, 2010, and Screamfest LA. Todd portrayed Reverend Zombie in Hatchet II, which was released in a limited number of theatres on October 1, 2010. His signature baritone voice narrated several works, including the 2021 documentary Invisible Threads: From Wireless to War. Todd returned as William Bludworth, when he filmed Final Destination Bloodlines in 2024.

This is normally achieved through regular blood tests, although continuous blood sugar testing equipment (Continuous Glucose Monitors or CGMs) are now becoming available which could help to refine this balancing act once widespread usage becomes common.

According to Popov's mother, Popov told her he could see how the Georgians fired on Tskhinvali one week before the war. The mother of Eldar Lotfullin, 23-year-old contract soldier, said that she was able to call her son for the last time at around 10 pm MSK on 7 August 2008. Eldar Lotfullin told journalist that the Georgian tanks fired on his barracks on 8 August. On 13 August, Izvestia reported that the unit (where Popov served) was participating in the exercises in the mountains of South Ossetia. Life.ru reported on Evgeny Parfenov that "22-year old contract soldier died on the first day of the bloody aggression in the Georgian-South Ossetian conflict zone, when a barrage of fire hit the peaceful town." The peacemaker's mother said that his son called her on 7 August, but she did not know that he was in South Ossetia until his death. On 12 August 2008, Moskovskij Komsomolets reported that one Russian regular army officer had said that he was preparing for the exercises in South Ossetia, but understood only at the last minute that he was going to war. On 12 August 2008, APN reported that the residents of North Ossetia–Alania were able to see the movement of a large number of troops towards the Roki Tunnel since the evening of 6 August; however, they could not believe that Russia was involved in the war until the morning of 8 August. In August 2008, Life.ru reported that 25-year old Aleksandr Shreider, who was serving in Rostov Oblast, called her mother on 5 August 2008 and told her that he was being sent to South Ossetia.

At temperatures greater than 44 °C (111 °F), proteins begin losing their three-dimensional shape and start breaking down. This results in cell and tissue damage. Many of the direct health effects of a burn are caused by failure of the skin to perform its normal functions, which include: protection from bacteria, skin sensation, body temperature regulation, and prevention of evaporation of the body's water. Disruption of these functions can lead to infection, loss of skin sensation, hypothermia, and hypovolemic shock via dehydration (i.e. water in the body evaporated away). Disruption of cell membranes causes cells to lose potassium to the spaces outside the cell and to take up water and sodium. In large burns (over 30% of the total body surface area), there is a significant inflammatory response. This results in increased leakage of fluid from the capillaries, and subsequent tissue edema. This causes overall blood volume loss, with the remaining blood suffering significant plasma loss, making the blood more concentrated. Poor blood flow to organs like the kidneys and gastrointestinal tract may result in kidney failure and stomach ulcers. Increased levels of catecholamines and cortisol can cause a hypermetabolic state that can last for years. This is associated with increased cardiac output, metabolism, a fast heart rate, and poor immune function.

The new constitution, proclaiming a democratic republic, direct universal suffrage, and the separation of powers, was promulgated on 4 November 1848. Under the new constitution, there was to be a single permanent Assembly of 750 members elected for a term of three years by the scrutin de liste. The Assembly would elect members of a Council of State to serve for six years. Laws would be proposed by the Council of State, to be voted on by the Assembly. The executive power was delegated to the president, who was elected for four years by direct universal suffrage, i.e. on a broader basis than that of the Assembly, and was not eligible for re-election. He was to choose his ministers, who, like him, would be responsible to the Assembly. Revision of this constitution was made practically impossible: it involved obtaining three times in succession a majority of three-quarters of the deputies in a special assembly. It was in vain that Jules Grévy—on behalf of those who perceived the obvious and inevitable risk of creating, under the name of a president, a monarch and indeed one who was more than a king at that—proposed that the head of the state should be no more than a removable president of the ministerial council. Lamartine, thinking that he was sure to be the choice of the electors under universal suffrage, won over the support of the Chamber, which did not even take the precaution of rendering ineligible the members of families which had reigned over France. It made the presidency an office dependent upon popular acclamation.

Sources: en.wikipedia.org

Reference notes

== Religious significance == In ancient Greek religion, the food of Zeus and the twelve Gods of Olympus was honey in the form of nectar and ambrosia. In the Hebrew Bible, the Promised Land (Canaan, the Land of Israel) is described 16 times as "the land of milk and honey" as a metaphor for its bounty. Of the 55 times the word "honey" appears in the Hebrew Bible, 16 are part of the expression "the land of milk and honey", and only twice is "honey" explicitly associated with bees, both being related to wild bees. Modern biblical researchers long considered that the original Hebrew word used in the Bible (דבש, devash) refers to the sweet syrup produced from figs or dates, because the domestication of the honey bee was completely undocumented through archaeology anywhere in the ancient Near East (excluding Egypt) at the time associated with the earlier biblical narratives (books of Exodus, Judges, Kings, etc.). In 2005, however, an apiary dating from the 10th century BC was found in Tel Rehov, Israel that contained 100 hives, estimated to produce half a ton of honey annually. This was, as of 2007, the only such finding made by archaeologists in the entire ancient Near East region, and it opens the possibility that biblical honey was indeed bee honey.

Asia: United Arab Emirates (17), Saudi Arabia (13), Kuwait (7), South Korea (9), Hong Kong (8), China (5), Bahrain (4), Malaysia (3), Macau (3), Qatar (3), Singapore (2). Europe: United Kingdom (178), Spain (44), France (41), Germany (35), Italy (10), Netherlands (4), Ireland (4), Switzerland (4), Sweden (3), Austria (2), Belgium (2), Denmark (2), Luxembourg (1), Czech Republic (1). North America: United States (1,517), Canada (72). Oceania: Australia (5).

=== P4 medicine === Since 2002 Hood has progressively expanded his vision of the future of medicine: first focusing on predictive and preventive (2P) Medicine; then predictive, preventive and personalized (3P) Medicine; and finally predictive, preventive, personalized and participatory, also known as P4 Medicine. Hood states that P4 Medicine is the convergence of systems medicine, big data and patient (consumer) driven healthcare and social networks. Hood envisions that by the mid-2020s each individual will be surrounded by a virtual cloud of billions of data points and will have the computational tools to analyze this data and produce simple approaches to optimize wellness and minimize disease for each individual. According to this view, the patient's demand for better healthcare will be the real driving force for the acceptance of P4 Medicine by the medical community. This driving force is exemplified by the movement known as the quantified self, which uses digital devices to monitor self-parameters such as weight, activity, sleep, diet, etc. His view is that P4 Medicine will transform the practice of medicine over the next decade, moving it from a largely reactive, disease-care approach to a proactive P4 approach that is predictive, preventive, personalized and participatory. In 2010, Hood co-founded the P4 Medicine institute (P4Mi), for the development of Predictive, Preventive, Personalized and Participatory (P4) Medicine. In 2021 Hood founded Phenome Health, a non profit focused on implementing his vision.

Bovine somatotropin or bovine somatotrophin (abbreviated bST and BST), or bovine growth hormone (BGH), is a peptide hormone produced by cows' pituitary glands. Like other hormones, it is produced in small quantities and is used in regulating metabolic processes. Recombinant bovine somatotropin (usually "rBST") is a synthetic version of the bovine growth hormone given to dairy cattle by injection to increase milk production. BST increases milk production by around 10 percent. Controversy over its safety for cows has led to rBST being banned in several countries, including the European Union since 1990, and Canada, Japan, Pakistan, Australia, New Zealand, and Argentina, as it has been found to increase health risks in cows. The Codex Alimentarius has not approved it as safe. The FDA approved it in 1993 and gave guidance to manufacturers that marking a product as "bST-free" or "rbST free" is misleading and a less misleading text would be "No significant difference has been shown between milk derived from rbST-treated and non-rbST-treated cows".

A major proponent of representative government was Itagaki Taisuke (1837–1919), a powerful Tosa leader who had resigned from the Council of State over the Korean affair in 1873. Itagaki sought peaceful, rather than rebellious, means to gain a voice in government. He started a school and a movement aimed at establishing a constitutional monarchy and a legislative assembly. Such movements were called The Freedom and People's Rights Movement. Itagaki and others wrote the Tosa Memorial in 1874, criticizing the unbridled power of the oligarchy and calling for the immediate establishment of representative government. Between 1871 and 1873, a series of land and tax laws were enacted as the basis for modern fiscal policy. Private ownership was legalized, deeds were issued, and lands were assessed at fair market value with taxes paid in cash rather than in kind as in pre-Meiji days and at slightly lower rates. Dissatisfied with the pace of reform after having rejoined the Council of State in 1875, Itagaki organized his followers and other democratic proponents into the nationwide Aikokusha (Society of Patriots) to push for representative government in 1878. In 1881, in an action for which he is best known, Itagaki helped found the Jiyūtō (Liberal Party), which favored French political doctrines. In 1882, Ōkuma Shigenobu established the Rikken Kaishintō (Constitutional Progressive Party), which called for a British-style constitutional democracy.

Sources: en.wikipedia.org

Notes from published material

b: black – The black mutation was discovered in 1910 by Thomas Hunt Morgan. The black mutation results in a darker colored body, wings, veins, and segments of the fruit fly's leg. This occurs due to the fly's inability to create beta-alanine, a beta amino acid. The phenotypic expression of this mutation varies based on the genotype of the individual; for example, whether the specimen is homozygotic or heterozygotic results in a darker or less dark appearance. This genetic mutation is x-linked recessive. bw: brown – The brown eye mutation results from inability to produce or synthesize pteridine (red) pigments, due to a point mutation on chromosome II. m: miniature – One of the first records of the miniature mutation of wings was also made by Thomas Hunt Morgan in 1911. He described the wings as having a similar shape as the wild-type phenotype. However, their miniature designation refers to the lengths of their wings, which do not stretch beyond their body and, thus, are notably shorter than the wild-type length. He also noted its inheritance is connected to the sex of the fly and could be paired with the inheritance of other sex-determined traits such as white eyes. The wings may also demonstrate other characteristics deviant from the wild-type wing, such as a duller and cloudier color. Miniature wings are 1.5 times shorter than wild-type but are believed to have the same number of cells. This is due to the lack of complete flattening by these cells, making the overall structure of the wing seem shorter in comparison.

=== Prohibitions and restrictions === Many markets refuse to list weapons or poisons. Markets such as the original Silk Road would refuse to list anything where the "purpose is to harm or defraud, such as stolen credit cards, assassinations, and weapons of mass destruction". Later markets such as Evolution ban "child pornography, services related to murder/assassination/terrorism, prostitution, Ponzi schemes, and lotteries", but allow the wholesaling of credit card data. The market in firearms appears to attract extra attention from law enforcement, as does the selling of other weapons such as certain types of knives and blades.

==== Cancer ==== The first study on trained dogs used for the detection of cancer was published by Willis et al. in 2004, observing that dogs were capable of detecting bladder cancer from urine samples. Subsequently, in 2004, Pickel et al. confirmed that dogs were able to successfully diagnose melanoma. In 2008, Horvath et al. confirmed dogs were successful in differentiating between cancerous and normal tissue and in distinguishing non-cancerous pathological tissue from cancerous tissue. Another study by Horvath et al. in 2010 found the dogs to show over 90% specificity in detecting ovarian cancer from blood samples, colorectal cancer from respiratory air, and prostate cancer from dog urine.

=== 1990–1992: Facelift and Sap === Alice in Chains soon became a top priority of the label, which released the band's first official recording in July 1990, a promotional EP called We Die Young. The EP's lead single, "We Die Young", became a hit on metal radio. After its success, the label rushed Alice in Chains' debut album into production with producer Dave Jerden. Cantrell stated the album was intended to have a "moody aura" that was a "direct result of the brooding atmosphere and feel of Seattle." The resulting album, Facelift, was released on August 21, 1990, peaking at number 42 in mid-1991 on the Billboard 200 chart. Facelift was not an instant success, selling under 40,000 copies in the first six months of release, until MTV added "Man in the Box" to regular daytime rotation. The single hit number 18 on the Mainstream rock charts, with the album's follow up single, "Sea of Sorrow", reaching number 27, and in six weeks Facelift sold 400,000 copies in the US. The album was a critical success, with Steve Huey of AllMusic citing Facelift as "one of the most important records in establishing an audience for grunge and alternative rock among hard rock and heavy metal listeners." Sammy Hagar claimed he invited the band to tour with Van Halen after he saw the music video for "Man In The Box" on MTV.

The excess of said expense, compared to the average cost of neighboring countries, was close to 0.79% of GDP. A Fedesarrollo study stated that the spending on defense and security carried out during 2004 "represented 4.5% of GDP", which does not have precedents in the history of Colombia. This is directly related to the Democratic Security Policy (Política de seguridad democrática) undertaken by the government of then-president Álvaro Uribe, who focused on military strikes on groups outside the law in order to regain security national. For the year 2004, the expenses of the Colombian Government in war and security were 6.59%, placing the country between the tenth that invest the most in war as a proportion of GDP.

Sources: en.wikipedia.org

Frequently asked questions

Is AOD-9604 the same as human growth hormone?

No, it is a synthetic peptide fragment corresponding to a small portion of hGH. It is not the full 191-amino-acid hormone and does not reproduce all of hGH's effects.

What is the exact length of AOD-9604?

It is commonly described as a 16-amino-acid peptide based on residues 176-191 of human growth hormone. Some sources vary in notation, so checking the stated sequence is useful.

Does AOD-9604 occur naturally?

It is not typically described as a standalone natural hormone. The sequence is derived from the C-terminal region of human growth hormone, but the synthetic peptide is a laboratory-made construct.

What is AOD-9604?

It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.

Network